AI Article Synopsis

  • Pathogenic missense variants in the synaptic vesicle protein synaptotagmin-1 (SYT1) lead to a neurodevelopmental disorder with motor delays, intellectual disabilities, and visual impairments due to impaired neurotransmitter release.
  • Research on cultured neurons has shown that specific variants in the SYT1 protein hinder exocytosis, causing varying degrees of dysfunction based on the variant's location.
  • The study establishes a direct correlation between the exocytic efficiency of SYT1 variants and the severity of developmental impairments, indicating a clear relationship between genetic mutations, neurotransmitter release, and functional outcomes, paving the way for potential therapeutic approaches.

Article Abstract

Background: Pathogenic missense variants in the essential synaptic vesicle protein synaptotagmin-1 (SYT1) cause a neurodevelopmental disorder characterised by motor delay and intellectual disability, hyperkinetic movement disorder, episodic agitation, and visual impairments. SYT1 is the presynaptic calcium sensor that triggers synchronous neurotransmitter release. We have previously shown that pathogenic variants around the calcium-sensing region of the critical C2B domain decrease synaptic vesicle exocytosis in neurons.

Methods: Here, we have used cultured hippocampal neurons transfected with SYT1-pHluorin to examine how variants within the C2A and C2B domain of SYT1 impact evoked exocytosis.

Findings: We show that recently identified variants within the facilitatory C2A domain of the protein (L159R, T196K, E209K, E219Q), as well as additional variants in the C2B domain (M303V, S309P, Y365C, G369D), share an underlying pathogenic mechanism, causing a graded and variant-dependent dominant-negative impairment in exocytosis. We establish that the extent of evoked exocytosis observed in vitro in the presence of SYT1 variants correlates with neurodevelopmental impacts of this disorder. Specifically, the severity of motor and communication impairments exhibited by individuals harbouring these variants correlates with multiple measures of exocytic efficiency.

Interpretation: Together, this suggests that there is a genotype-function-phenotype relationship in SYT1-associated neurodevelopmental disorder, centring impaired evoked neurotransmitter release as a common pathogenic driver. Moreover, this points toward a direct link between control of neurotransmitter release and development of adaptive functions, providing a tractable target for therapeutic amelioration.

Funding: Australian National Health and Medical Research Council, UK Medical Research Council, Great Ormond Street Hospital Children's Charity, University of Melbourne.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564929PMC
http://dx.doi.org/10.1016/j.ebiom.2024.105416DOI Listing

Publication Analysis

Top Keywords

neurotransmitter release
16
neurodevelopmental disorder
12
c2b domain
12
evoked neurotransmitter
8
adaptive functions
8
syt1-associated neurodevelopmental
8
synaptic vesicle
8
variants correlates
8
medical council
8
variants
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!